Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction — Results of the Aldo-DHF trial. Int J Cardiol. 2013 Nov 30;169(6):408-17(DZHK-authors: Edelmann, Tschöpe, Herrmann-Lingen, Halle, Hasenfuss,...
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy, Am J Human Genetics 93, 67–77, 2013(DZHK-authors: Berger, Hübner, Kramer, Klaassen)
Inhibition of Microrna-92a Protects against Ischemia-Reperfusion Injury in a Large Animal Model. Circulation (2013) 128:1066-1075 (DZHK-authors: Hinkel, Zeiher, Kupatt, Dimmeler)
Ca2+/Calmodulin-Dependent Protein Kinase Ii and Protein Kinase a Differentially Regulate Sarcoplasmic Reticulum Ca2+ Leak in Human Cardiac Pathology, Circulation 128, 970-981, (2013)(DZHK-authors: Toischer, Hasenfuss, Maier, Sossalla)
Effect of Spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The Aldo-DHF Randomized Controlled Trial. JAMA (2013) 309: 781-791. (DZHK-authors: Edelmann, Wachter, Tschöpe, Herrmann-Lingen, Halle, Hasenfuss)